10611368|t|Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease.
10611368|a|We quantified the amount of amyloid beta-peptide (Abeta) immunoreactivity as well as amyloid deposits in a large cohort of transgenic mice overexpressing the V717F human amyloid precursor protein (APP(V717F+/-) TG mice) with no, one, or two mouse apolipoprotein E (Apoe) alleles at various ages. Remarkably, no amyloid deposits were found in any brain region of APP(V717F+/-) Apoe(-/-) TG mice as old as 22 mo of age, whereas age-matched APP(V717F +/-) Apoe(+/-) and Apoe(+/+) TG mice display abundant amyloid deposition. The amount of Abeta immunoreactivity in the hippocampus was also markedly reduced in an Apoe gene dose-dependent manner (Apoe(+/+) > Apoe(+/-) >> Apoe(-/-)), and no Abeta immunoreactivity was detected in the cerebral cortex of APP(V717F+/-) Apoe(-/-) TG mice at any of the time points examined. The absence of apolipoprotein E protein (apoE) dramatically reduced the amount of both Abeta(1-40) and Abeta(1-42) immunoreactive deposits as well as the resulting astrogliosis and microgliosis normally observed in APP(V717F) TG mice. ApoE immunoreactivity was detected in a subset of Abeta immunoreactive deposits and in virtually all thioflavine-S-fluorescent amyloid deposits. Because the absence of apoE alters neither the transcription or translation of the APP(V717F) transgene nor its processing to Abeta peptide(s), we postulate that apoE promotes both the deposition and fibrillization of Abeta, ultimately affecting clearance of protease-resistant Abeta/apoE aggregates. ApoE appears to play an essential role in amyloid deposition in brain, one of the neuropathological hallmarks of Alzheimer's disease.
10611368	0	16	Apolipoprotein E	Gene	11816
10611368	34	52	amyloid deposition	Disease	MESH:D058225
10611368	64	69	V717F	ProteinMutation	tmVar:p|SUB|V|717|F;HGVS:p.V717F;VariantGroup:0;OriginalGene:11820;CorrespondingGene:351;RS#:63750264;CorrespondingSpecies:10090;CA#:127792
10611368	82	87	mouse	Species	10090
10611368	97	116	Alzheimer's disease	Disease	MESH:D000544
10611368	168	173	Abeta	Gene	11820
10611368	203	219	amyloid deposits	Disease	MESH:D058225
10611368	252	256	mice	Species	10090
10611368	276	281	V717F	ProteinMutation	tmVar:p|SUB|V|717|F;HGVS:p.V717F;VariantGroup:0;OriginalGene:11820;CorrespondingGene:351;RS#:63750264;CorrespondingSpecies:10090;CA#:127792
10611368	282	287	human	Species	9606
10611368	288	313	amyloid precursor protein	Gene	351
10611368	319	324	V717F	ProteinMutation	tmVar:p|SUB|V|717|F;HGVS:p.V717F;VariantGroup:0;OriginalGene:11820;CorrespondingGene:351;RS#:63750264;CorrespondingSpecies:10090;CA#:127792
10611368	332	336	mice	Species	10090
10611368	359	364	mouse	Species	10090
10611368	365	381	apolipoprotein E	Gene	11816
10611368	383	387	Apoe	Gene	11816
10611368	429	445	amyloid deposits	Disease	MESH:D058225
10611368	484	489	V717F	ProteinMutation	tmVar:p|SUB|V|717|F;HGVS:p.V717F;VariantGroup:0;OriginalGene:11820;CorrespondingGene:351;RS#:63750264;CorrespondingSpecies:10090;CA#:127792
10611368	494	498	Apoe	Gene	11816
10611368	507	511	mice	Species	10090
10611368	560	565	V717F	ProteinMutation	tmVar:p|SUB|V|717|F;HGVS:p.V717F;VariantGroup:0;OriginalGene:11820;CorrespondingGene:351;RS#:63750264;CorrespondingSpecies:10090;CA#:127792
10611368	571	575	Apoe	Gene	11816
10611368	585	589	Apoe	Gene	11816
10611368	598	602	mice	Species	10090
10611368	620	638	amyloid deposition	Disease	MESH:D058225
10611368	654	659	Abeta	Gene	11820
10611368	728	732	Apoe	Gene	11816
10611368	761	765	Apoe	Gene	11816
10611368	773	777	Apoe	Gene	11816
10611368	786	790	Apoe	Gene	11816
10611368	805	810	Abeta	Gene	11820
10611368	871	876	V717F	ProteinMutation	tmVar:p|SUB|V|717|F;HGVS:p.V717F;VariantGroup:0;OriginalGene:11820;CorrespondingGene:351;RS#:63750264;CorrespondingSpecies:10090;CA#:127792
10611368	881	885	Apoe	Gene	11816
10611368	894	898	mice	Species	10090
10611368	976	980	apoE	Gene	11816
10611368	1099	1111	astrogliosis	Disease	MESH:D005911
10611368	1116	1128	microgliosis	Disease	
10611368	1154	1159	V717F	ProteinMutation	tmVar:p|SUB|V|717|F;HGVS:p.V717F;VariantGroup:0;OriginalGene:11820;CorrespondingGene:351;RS#:63750264;CorrespondingSpecies:10090;CA#:127792
10611368	1164	1168	mice	Species	10090
10611368	1170	1174	ApoE	Gene	11816
10611368	1220	1225	Abeta	Gene	11820
10611368	1271	1284	thioflavine-S	Chemical	MESH:C009462
10611368	1297	1313	amyloid deposits	Disease	MESH:D058225
10611368	1338	1342	apoE	Gene	11816
10611368	1402	1407	V717F	ProteinMutation	tmVar:p|SUB|V|717|F;HGVS:p.V717F;VariantGroup:0;OriginalGene:11820;CorrespondingGene:351;RS#:63750264;CorrespondingSpecies:10090;CA#:127792
10611368	1441	1446	Abeta	Gene	11820
10611368	1477	1481	apoE	Gene	11816
10611368	1533	1538	Abeta	Gene	11820
10611368	1593	1598	Abeta	Gene	11820
10611368	1599	1603	apoE	Gene	11816
10611368	1616	1620	ApoE	Gene	11816
10611368	1658	1676	amyloid deposition	Disease	MESH:D058225
10611368	1729	1748	Alzheimer's disease	Disease	MESH:D000544
10611368	Association	MESH:D005911	11816
10611368	Association	MESH:C009462	11816
10611368	Association	MESH:D000544	RS#:63750264;HGVS:p.V717F;CorrespondingGene:351
10611368	Negative_Correlation	11816	11820
10611368	Association	MESH:C009462	MESH:D058225
10611368	Association	MESH:D058225	11816
10611368	Association	MESH:D000544	351

